What Is Cannabigerol (CBG)?

Verywell Mind articles are reviewed by board-certified physicians and mental healthcare professionals. Medical Reviewers confirm the content is thorough and accurate, reflecting the latest evidence-based research. Content is reviewed before publication and upon substantial updates. Learn more.

Cannabigerol (CBG) is a type of cannabinoid found in the cannabis plant. It’s often referred to as the "mother of all cannabinoids." This is because other cannabinoids are derived from cannabigerolic acid (CBGA), an acidic form of CBG.

CBG is found in smaller quantities than other cannabinoids in cannabis plants, such as cannabidiol (CBD) and tetrahydrocannabinol (THC). This makes consumer products derived from cannabigerol rare and often expensive. However, CBG is growing in popularity because of the many potential benefits the cannabinoid offers.

The Most Important Thing to Know About About CBG

Although CBG is derived from plants, research is in its early stages as to the potential benefits and risks associated with its use. Additionally, marijuana is addictive, so using this drug for its potential CBG benefits may do more harm than good.

CBG Concentration in Plants

CBG is derived from young cannabis plants, which contain higher amounts of this cannabinoid than plants that are fully developed. Both CBD and THC start as CBGA, an acidic form of CBG. This is why younger cannabis plants contain higher concentrations.

Conversely, in fully developed plants with high concentrations of THC and CBD, you’ll find very low concentrations of CBG. In most plant strains, only 1% of CBG can be found. This happens because most of the CBG has already been converted as the plant developed.

Some strains of cannabis have higher CBG content due to their genetic and biochemical makeup. Because of the difficulty in getting CBG, cannabis growers have been experimenting with cross-breeding and genetic manipulation to help cannabis plants produce more of this cannabinoid.

White CBG, Super Glue CBG, and Jack Frost CBG are strains specifically cultivated to produce higher quantities of CBG.

How CBG Works

CBG is processed by the body’s endocannabinoid system. The endocannabinoid system is made up of molecules and receptors that are responsible for keeping our bodies in an optimal state, regardless of what’s going on in our external environment.

In our bodies, CBG imitates endocannabinoids , the natural compounds our body makes. But it does not have THC's psychotropic effects, so it will not give you a high.

Cannabinoid Receptors in the Body

Our body contains two types of cannabinoid receptors—CB1 and CB2. CB1 receptors are found in the nervous system and brain, while CB2 receptors are located in the immune system and other areas of the body.

CBG works by binding to both receptors, where it’s thought to strengthen the function of anandamide. Anandamide is one of many neurotransmitters in the brain. It plays a role in enhancing pleasure and motivation, regulating appetite and sleep, and alleviating pain.

Potential Benefits of CBG

Research shows that CBG may have therapeutic effects. While more research is needed to learn the exact effects of this cannabinoid and its potential benefits, here are a few of their findings.

Anxiety and Depression

One small-scale study found that the number one reason people used cannabis preparations high in CBG was to reduce anxiety, with one in three using it to ease depression. Most of the users reported that they felt that CBG was more effective for these purposes than conventional medicines.

Chronic Pain

In the study mentioned above, the second-most common reason people used CBG was for chronic pain, with 73.9% reporting that it worked better than traditional medicines. Chronic pain is pain that lasts three months or more. This type of condition impacts roughly one in five U.S. adults or around 51.6 million Americans.

Inflammatory Bowel Disease (IBD)

According to one review, between 15% and 40% of people with inflammatory bowel disease (IBD) use cannabis and cannabinoids to increase their appetite as well as to reduce their pain. Although studies have found promise for its effects on IBD, researchers added that high-quality evidence is lacking, as is advice as to the proper dose and mode of administration.

Glaucoma

Individuals with high eye pressure, also known as intraocular pressure (IOP), are at a greater risk of developing glaucoma. Several studies have looked at the impact of cannabinoids on IOP. Many have found that these cannabis derivatives help lower IOP in both humans and animals, making them a potential glaucoma treatment.

Huntington's Disease

Huntington's disease causes a breakdown of nerve cells in the brain. Cannabigerol appears to have a positive effect on cell viability while also protecting certain cells (N2a cells) from the toxic effects of excitatory neurotransmitters that, when activated too long, lead to cell death.

Cancer

A 2021 meta-analysis reports that CBG appears to not only stop breast cancer cells from increasing in numbers but may also kill off inflammatory cells associated with this cancer type.

Bacterial Infections

A 2020 study on the antibiotic potential of cannabis found that CBG has antibacterial properties, especially against methicillin-resistant strains of Staphylococcus aureus. Staphylococcus aureus is also known as MRSA, a drug-resistant bacteria that causes staph infections.

How CBG is Consumed

The most common form of commercially available CBG is oil, but it is rare and expensive. As an alternative, broad-spectrum CBD oils contain almost all the cannabinoids of cannabis.

Broad-spectrum CBD oils also contain compounds called terpenes, which are responsible for the plant's smell and are found in many plants, including fruit and herbs. Using cannabinoids together with terpenes is said to increase their combined effectiveness through a phenomenon called the entourage effect.

Some people consume CBG by smoking marijuana. While this is one way to ingest CBG, marijuana addiction is possible. This is classified as cannabis use disorder and can negatively affect your mental and physical health while also hurting your personal and social relationships.

If you or a loved one are struggling with substance use or addiction, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 1-800-662-4357 for information on support and treatment facilities in your area.

For more mental health resources, see our National Helpline Database.

Side Effects of CBG

Some people experience side effects when taking CBG, with some of the most common being:

• Dry mouth
• Sleepiness
• Increased appetite
• Dry eyes

Research on the potential side effects and drug interaction risks of CBG and other cannabinoids is expanding, but not enough has been completed yet to reliably determine either.

CBG vs. CBD

CBG shares many similarities with CBD:

• Both act on the endocannabinoid system.
• Neither is psychoactive, meaning they don't produce a "high."
• Each one can counteract THC's psychotropic effects.

One of the biggest differences between CBD and CBG is their prevalence within the cannabis plant. Remember that most cannabis plants contain only 1% CBG. Conversely, their level of CBD is much higher, with some research indicating that CBD is the second-most abundant compound found within these plants.

CBG also interacts differently with the endocannabinoid system than CBD. CBG binds directly to both CB1 and CB2 receptors and might deliver its benefits to the system more efficiently.

Summary

Although CBG shows promise for its potential health benefits, more research must be conducted to learn its side effects, risks, and more. Until we understand how this cannabinoid works more completely, it remains unclear whether it is safe to use and, if so, in what amounts it would be most therapeutic.

Verywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

1. Perez E, Fernandez JR, Fitzgerald C, Rouzard K, Tamura M, Savile C. In vitro and clinical evaluation of cannabigerol (CBG) produced via yeast biosynthesis: A cannabinoid with a broad range of anti-inflammatory and skin health-boosting properties. Molecules. 2022;27(2):491. doi:10.3390/molecules27020491
2. Mudge EM, Murch SJ, Brown PN. Chemometric analysis of cannabinoids: Chemotaxonomy and domestication syndrome. Sci Rep. 2018;8:13090. doi:10.1038/s41598-018-31120-2
3. Jastrząb A, Jarocka-Karpowicz I, Skrzydlewska E. The origin and biomedical relevance of cannabigerol. Int J Mol Sci. 2022;23(14):7929. doi:10.3390/ijms23147929
4. Russo EB, Cuttler C, Cooper ZD, Stueber A, Whiteley VL, Sexton M. Survey of patients employing cannabigerol-predominant cannabis preparations: Perceived medical effects, adverse events, and withdrawal symptoms. Cannabis Cannabinoid Res. 2022;7(5):706-716. doi:10.1089/can.2021.0058
5. Centers for Disease Control and Prevention. Chronic pain among adults — United States, 2019-2021.
6. Nduma BN, Mofor KA, Tatang J, Ekhator C, Ambe S, Fonkem E. The use of cannabinoids in the treatment of inflammatory bowel disease (IBD): A review of the literature. Cureus. 2023;15(3):e36148. doi:10.7759/cureus.36148
7. National Eye Institute. Glaucoma and eye pressure.
8. Aloway A, Kumar A, Laun AS, Song ZH. Chapter 77 - Cannabinoid regulation of intraocular pressure: Human and animal studies, cellular and molecular targets. Handbook of Cannabis and Related Pathologies. 2017:748-759. doi:10.1016/B978-0-12-800756-3.00088-0
9. Stone NL, Murphy AJ, England TJ, O'Sullivan SE. A systematic review of minor phytocannabinoids with promising neuroprotective potential. Brit J Pharmacol. 2020;177(19):4330-4352. doi:10.1111/bph.15185
10. Snell A. Meta-analysis of cannabigerol effects of breast cancer tissue cells. University of Northern Colorado.
11. Farha MA, El-Halfawy OM, Gale RT, et al. Uncovering the hidden antibiotic potential of cannabis.ACS Infect Dis. 2020;6(3):338-346. doi:10.1021/acsinfecdis.9b00419
12. Ferber SG, Namdar D, Hen-Shoval D, et al. The "entourage effect": Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. Curr Neuropharmacol. 2020;18(2):87-96. doi:10.2174/1570159X17666190903103923
13. Yale Medicine. Cannabis/marijuana use disorder.
14. Calapai F, Cardia L, Esposito E, et al. Pharmacological aspects and biological effects of cannabigerol and its synthetic derivatives. Evid Based Complement Alternat Med. 2022;2022:3336516. doi:10.1155/2022/3336516
15. de Almeida D, Devi LA. Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect. 2020;8(6):e00682. doi:10.1002/prp2.682
16. Dawidowicz AJ, Olszowy-Tomczyk M, Typek R. CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action. Fitoterapia. 2021;152:104915. doi:10.1016/j.fitote.2021.104915

By Toketemu Ohwovoriole
Toketemu has been multimedia storyteller for the last four years. Her expertise focuses primarily on mental wellness and women’s health topics.

laying on blanket in the park" width="400" height="250" />

• Meet Our Review Board
• About Us
• Editorial Process
• Diversity Pledge
• Privacy Policy
• In the News
• Advertise
• Terms of Service
• Careers
• Contact
• EU Privacy
• Crisis Support

Verywell Mind's content is for informational and educational purposes only. Our website is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

We Care About Your Privacy

We and our 100 partners store and/or access information on a device, such as unique IDs in cookies to process personal data. You may accept or manage your choices by clicking below, including your right to object where legitimate interest is used, or at any time in the privacy policy page. These choices will be signaled to our partners and will not affect browsing data.

We and our partners process data to provide:

Store and/or access information on a device. Use limited data to select advertising. Create profiles for personalised advertising. Use profiles to select personalised advertising. Create profiles to personalise content. Use profiles to select personalised content. Measure advertising performance. Measure content performance. Understand audiences through statistics or combinations of data from different sources. Develop and improve services. Use limited data to select content. List of Partners (vendors)